Krystal Biotech (NASDAQ:KRYS) Now Covered by Jefferies Financial Group
Jefferies Financial Group started coverage on shares of Krystal Biotech (NASDAQ:KRYS – Free Report) in a report released on Wednesday, Marketbeat reports. The brokerage issued a buy rating and a $245.00 price target on the stock. A number of other equities analysts also recently commented on the stock. Cantor Fitzgerald reiterated an “overweight” rating and […]
Jefferies Financial Group started coverage on shares of Krystal Biotech (NASDAQ:KRYS – Free Report) in a report released on Wednesday, Marketbeat reports. The brokerage issued a buy rating and a $245.00 price target on the stock. A number of other equities analysts also recently commented on the stock. Cantor Fitzgerald reiterated an “overweight” rating and […]
